Shacham Abulafia, A., Shemesh, S., Rosenmann, L., Berger, T., Leader, A., Sharf, G., . . . Rozovski, U. (2020). Health-Related Quality of Life in Patients with Chronic Myeloid Leukemia Treated with First- Versus Second-Generation Tyrosine Kinase Inhibitors. J Clin Med.
Chicago ZitierstilShacham Abulafia, Adi, Sivan Shemesh, Lena Rosenmann, Tamar Berger, Avi Leader, Giora Sharf, Pia Raanani, und Uri Rozovski. "Health-Related Quality of Life in Patients With Chronic Myeloid Leukemia Treated With First- Versus Second-Generation Tyrosine Kinase Inhibitors." J Clin Med 2020.
MLA ZitierstilShacham Abulafia, Adi, et al. "Health-Related Quality of Life in Patients With Chronic Myeloid Leukemia Treated With First- Versus Second-Generation Tyrosine Kinase Inhibitors." J Clin Med 2020.